Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-11

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 26-32

  D'Orazio, T J ^a   Mayhew, E ^a   Niederkorn, J Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE;

ANIMAL CELL; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOWN REGULATION; EYE; HISTOCOMPATIBILITY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SPLEEN CELL; TH1 CELL;

EID: 0035173022     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.26     Document Type: Article

References (37)

1. Fas ligand-induced apoptosis as a mechanism of immune privilege
2. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments
3. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye
4. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye
5. Immune deviation in relation to ocular immune privilege
6. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen
7. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigenpresenting cells in immune deviation of the ocular type
8. Role of splenic B cells in the immune privilege of the anterior chamber of the eye
9. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID)
10. Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 suppression of T helper 2 responses
11. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens
12. B cells turn off virgin but not memory T cells
13. Parameters of tolerance induction by antigen targeted to B lymphocytes
14. In the absence of a CD40 signal, B cells are tolerogenic
15. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand
16. CD40 ligand induction on T cell subsets by peptide-presenting B cells: Implications for development of the primary T and B cell response
17. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood
18. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID
19. Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts: Kinetic evidence that the transfer of proteins to lysosomes is not irreversible
20. Interstitial lung macrophages interact with dendritic cells to present antigenic peptides derived from particulate antigens to T cells
21. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system
22. + T cells is regulated by the antigen-presenting cell
23. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β
24. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis
25. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye
26. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β
27. Biochemical identification of the Qa-1 alloantigen
28. Structural and functional characteristics of the class IB molecule. Qa-1
29. The Qa-1 antigenic system: Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions
30. Evidence for antigen presentation by the class Ib molecule. Qa-1
31. Role of Th1 and Th2 cells in anterior Chamber-associated immune deviation
32. Alterations in cytokine production following intraocular injection of soluble protein antigen: Impairment in IFN-γ and induction of TGF-β and IL-4 production
33. The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response
34. + T cells
35. +T cells restricted by the MHC class IB molecule. Qa-1
36. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
37. CDI.1 expression by mouse antigen-presenting cells and marginal zone B. cells